Literature DB >> 26116871

Elevated amniotic fluid lactate predicts labor disorders and cesarean delivery in nulliparous women at term.

Martina Murphy1, Michelle Butler2, Barbara Coughlan3, Donal Brennan4, Colm O'Herlihy4, Michael Robson5.   

Abstract

OBJECTIVE: We sought to assess amniotic fluid lactate (AFL) at diagnosis of spontaneous labor at term (≥37 weeks) as a predictor of labor disorders (dystocia) and cesarean delivery (CD). STUDY
DESIGN: This was a single-institution, prospective cohort study of 905 singleton, cephalic, term (≥37 weeks) nulliparous women in spontaneous labor. A standard management of labor (active management of labor) including a standard oxytocin regimen up to a maximum dose of 30 mU/min was applied. AFL was measured using a point-of-care device (LMU061; ObsteCare, Stockholm, Sweden). Labor arrest in the first stage of labor was defined as the need for oxytocin when cervical dilatation was <1 cm/h over 2 hours and in the second stage of labor by poor descent and rotation over 1 hour. Standard statistical analysis included analysis of variance, Pearson correlations, and binary logistic regression. Unsupervised decision tree analysis with 10-fold cross-validation was used to identify AFL thresholds.
RESULTS: AFL was normally distributed and did not correlate with age, body mass index, or gestation. Unsupervised decision tree analysis demonstrated that AFL could be divided into 3 groups: 0-4.9 mmol/L (n = 118), 5.0-9.9 mmol/L (n = 707), and ≥10.0 mmol/L (n = 80). Increasing AFL was associated with higher total oxytocin dose (P = .001), labor disorders (P = .005), and CD (P ≤ .001). Multivariable regression analysis demonstrated that women with AFL ≥5.0-9.9 mmol/L (odds ratio [OR], 1.6; 95% confidence interval [CI], 1.06-2.39) and AFL ≥10.0 mmol/L (OR, 1.72; 95% CI, 1.01-2.93) were independent predictors of a labor disorder. AFL ≥5.0-9.9 mmol/L did not predict CD but multivariable analysis confirmed that AFL ≥10.0 mmol/L was an independent predictor of CD (OR, 3.35; 95% CI, 1.73-6.46). AFL ≥5.0-9.9 mmol/L had a sensitivity of 89% in predicting a labor disorder and a sensitivity of 93% in predicting CD with a 97% negative predictive value. AFL ≥10.0 mmol/L was highly specific but lacked sensitivity for CD. There was no difference in birthweight of infants according to labor disorder and delivery method.
CONCLUSION: AFL at diagnosis of labor in spontaneously laboring single cephalic nulliparous term women is an independent predictor of a labor disorder and CD. These data suggest that women with AFL between 5.0-9.9 mmol/L with a labor disorder may be amenable to correction using the active management of labor protocol.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  active management of labor; amniotic fluid lactate; cesarean delivery; labor disorder (dystocia)

Mesh:

Year:  2015        PMID: 26116871     DOI: 10.1016/j.ajog.2015.06.035

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  3 in total

1.  Lactate in Amniotic Fluid: Predictor of Labor Outcome in Oxytocin-Augmented Primiparas' Deliveries.

Authors:  Eva Wiberg-Itzel; Andrea B Pembe; Hans Järnbert-Pettersson; Margareta Norman; Anna-Carin Wihlbäck; Irene Hoesli; Monya Todesco Bernasconi; Elie Azria; Helena Åkerud; Elisabet Darj
Journal:  PLoS One       Date:  2016-10-26       Impact factor: 3.240

2.  Ozone-induced fetal growth restriction in rats is associated with sexually dimorphic placental and fetal metabolic adaptation.

Authors:  Colette N Miller; Janice A Dye; Andres R Henriquez; Erica J Stewart; Katelyn S Lavrich; Gleta K Carswell; Hongzu Ren; Danielle L Freeborn; Samantha J Snow; Mette C Schladweiler; Judy H Richards; Prasada R S Kodavanti; Anna Fisher; Brian N Chorley; Urmila P Kodavanti
Journal:  Mol Metab       Date:  2020-10-05       Impact factor: 7.422

3.  Labor induction with oxytocin in pregnant rats is not associated with oxidative stress in the fetal brain.

Authors:  Tusar Giri; Jia Jiang; Zhiqiang Xu; Ronald McCarthy; Carmen M Halabi; Eric Tycksen; Alison G Cahill; Sarah K England; Arvind Palanisamy
Journal:  Sci Rep       Date:  2022-02-24       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.